Sensing mechanisms involved in Ca2+ and Mg 2+ homeostasis

Kidney International

Volumn 82, Issue 11, 2012, Pages 1157-1166

  Ferrè, Silvia ^a   Hoenderop, Joost G J ^a   Bindels, René J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cation sensing; ectopic calcifications; kidney disease; mineral and bone disorder

Indexed keywords

CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM ION; CALCIUM SENSING RECEPTOR; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; MAGNESIUM ION; PARATHYROID HORMONE; PROTON PUMP INHIBITOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; VANILLOID RECEPTOR 5; VITAMIN D DERIVATIVE;

BARTTER SYNDROME; BLOOD VESSEL CALCIFICATION; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOMAGNESEMIA; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MAGNESIUM METABOLISM; NONHUMAN; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM; WATER ABSORPTION;

EID: 84869232415     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.179     Document Type: Review

References (132)

1. Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580. (Pubitemid 24035999)
2. Garrett JE, Capuano IV, Hammerland LG et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270: 12919-12925.
3. Aida K, Koishi S, Tawata M et al. Molecular cloning of a putative Ca(2+)-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 1995; 214: 524-529.
4. Bai M. Structure-function relationship of the extracellular calciumsensing receptor. Cell Calcium 2004; 35: 197-207. (Pubitemid 38292363)
5. Mentaverri R, Yano S, Chattopadhyay N et al. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J 2006; 20: 2562-2564.
6. Oda Y, Tu CL, Pillai S et al. The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation. J Biol Chem 1998; 273: 23344-23352. (Pubitemid 28417522)
7. Tu CL, Chang W, Xie Z et al. Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J Biol Chem 2008; 283: 3519-3528.
8. Tu CL, Chang W, Bikle DD. The calcium-sensing receptor-dependent regulation of cell-cell adhesion and keratinocyte differentiation requires Rho and filamin A. J Invest Dermatol 2011; 131: 1119-1128.
9. Chang W, Tu C, Chen TH et al. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 2008; 1: ra1.
10. Dvorak-Ewell MM, Chen TH, Liang N et al. Osteoblast extracellular Ca2+-sensing receptor regulates bone development, mineralization, and turnover. J Bone Miner Res 2011; 26: 2935-2947.
11. Pollak MR, Brown EM, Estep HL et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 1994; 8: 303-307.
12. Marx SJ, Spiegel AM, Brown EM et al. Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med 1978; 65: 235-242. (Pubitemid 8392382)
13. Marx SJ, Fraser D, Rapoport A. Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 1985; 78: 15-22. (Pubitemid 15159612)
14. Hough TA, Bogani D, Cheeseman MT et al. Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Proc Natl Acad Sci USA 2004; 101: 13566-13571. (Pubitemid 39238443)
15. Ho C, Conner DA, Pollak MR et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995; 11: 389-394.
16. Kapur K, Johnson T, Beckmann ND et al. Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calciumsensing receptor (CASR) gene. PLoS Genet 2010; 6: e1001035.
17. Kestenbaum B, Glazer NL, Kö ttgen A et al. Common genetic variants associate with serum phosphorus concentration. J Am Soc Nephrol 2010; 21: 1223-1232.
18. de Groot T, Lee K, Langeslag M et al. Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation. J Am Soc Nephrol 2009; 20: 1693-1704.
19. Russell J, Lettieri D, Sherwood LM. Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 1986; 119: 2864-2866. (Pubitemid 17193160)
20. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 2002; 277: 30337-30350.
21. Kantham L, Quinn SJ, Egbuna OI et al. The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. Am J Physiol Endocrinol Metab 2009; 297: E915-E923.
22. Brown EM. Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411.
23. Ferment O, Garnier PE, Touitou Y. Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man. J Endocrinol 1987; 113: 117-122. (Pubitemid 17052707)
24. Inaba M, Okuno S, Imanishi Y et al. Magnesium deficiency enhances secretion of parathyroid hormone in normal and 5/6-nephrectomized uremic rats. J Endocrinol Invest 1992; 15: 135-142.
25. Habener JF, Potts Jr JT. Relative effectiveness of magnesium and calcium on the secretion and biosynthesis of parathyroid hormone in vitro. Endocrinology 1976; 98: 197-202.
26. Brown EM. Relationship of 30,50-adenosine monophosphate accumulation to parathyroid hormone release in dispersed cells from pathological human parathyroid tissue. J Clin Endocrinol Metab 1981; 52: 961-968. (Pubitemid 13237485)
27. Navarro JF, Mora C, Jiménez A et al. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 1999; 34: 43-48. (Pubitemid 29318794)
28. Navarro JF, Mora C, Macia M et al. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int 1999; 19: 455-461. (Pubitemid 30015432)
29. Chang W, Pratt S, Chen TH et al. Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera. J Bone Miner Res 1998; 13: 570-580. (Pubitemid 28163008)
30. Quitterer U, Hoffmann M, Freichel M et al. Paradoxical block of parathormone secretion is mediated by increased activity of G alpha subunits. J Biol Chem 2001; 276: 6763-6769.
31. Li FY, Chaigne-Delalande B, Kanellopoulou C et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 2011; 475: 471-476.
32. Riccardi D, Park J, Lee WS et al. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 1995; 92: 131-135.
33. Brown AJ, Zhong M, Finch J et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 1996; 270: F454-F460.
34. Riccardi D, Traebert M, Ward DT et al. Dietary phosphate and parathyroid hormone alter the expression of the calcium-sensing receptor (CaR) and the Na+-dependent Pi transporter (NaPi-2) in the rat proximal tubule. Pflugers Arch 2000; 441: 379-387. (Pubitemid 32128180)
35. Bland R, Walker EA, Hughes SV et al. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 1999; 140: 2027-2034. (Pubitemid 30636439)
36. Bajwa A, Horst RL, Beckman MJ. Gene profiling the effects of calcium deficiency versus 1,25-dihydroxyvitamin D induced hypercalcemia in rat kidney cortex. Arch Biochem Biophys 2005; 438: 182-194. (Pubitemid 40798018)
37. Hou J, Renigunta A, Gomes AS et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci USA 2009; 106: 15350-15355.
38. Ikari A, Okude C, Sawada H et al. Activation of a polyvalent cationsensing receptor decreases magnesium transport via claudin-16. Biochim Biophys Acta 2008; 1778: 283-290.
39. Greger R, Schlatter E. Properties of the lumen membrane of the cortical thick ascending limb of Henle's loop of rabbit kidney. Pflugers Arch 1983; 396: 315-324. (Pubitemid 13157563)
40. Huang C, Miller RT. Novel Ca receptor signaling pathways for control of renal ion transport. Curr Opin Nephrol Hypertens 2010; 19: 106-112.
41. Simon DB, Karet FE, Rodriguez-Soriano J et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K\+ channel, ROMK. Nat Genet 1996; 14: 152-156. (Pubitemid 26338794)
42. Pollak MR, Brown EM, Estep HL et al. Autosomal dominant hypocalcaemia caused by a Ca(2\+)-sensing receptor gene mutation. Nat Genet 1994; 8: 303-307.
43. Gamba G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol Rev 2005; 85: 423-493. (Pubitemid 40404634)
44. Dimke H, Hoenderop JG, Bindels RJ. Hereditary tubular transport disorders: multiplications for renal handling of Ca2+ and Mg2+. Clin Sci (Lond) 2010; 118: 1-18.
45. Schlingmann KP, Weber S, Peters M et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31: 166-170.
46. Walder RY, Landau D, Meyer P et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002; 31: 171-174.
47. Cha SK, Huang C, Ding Y et al. Calcium-sensing receptor decreases cell surface expression of the inwardly rectifying K+ channel Kir4.1. J Biol Chem 2011; 286: 1828-1835.
48. Scholl UI, Choi M, Liu T et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA 2009; 106: 5842-5847.
49. Bockenhauer D, Feather S, Stanescu HC et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009; 360: 1960-1970.
50. Topala CN, Schoeber JP, Searchfield LE et al. Activation of the Ca2+-sensing receptor stimulates the activity of the epithelial Ca2+ channel TRPV5. Cell Calcium 2009; 45: 331-339.
51. Hoenderop JG, Chon H, Gkika D et al. Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice. Kidney Int 2004; 65: 531-539. (Pubitemid 38130647)
52. Hoenderop JG, Muller D, Van Der Kemp AW et al. Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 2001; 12: 1342-1349. (Pubitemid 32666317)
53. de Groot T, Kovalevskaya NV, Verkaart S et al. Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone. Mol Cell Biol 2011; 31: 2845-2853.
54. Renkema KY, Velic A, Dijkman HB et al. The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. J Am Soc Nephrol 2009; 20: 1705-1713.
55. Chang W, Tu C, Chen TH et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999; 140: 5883-5893. (Pubitemid 30645377)
56. Dvorak MM, Siddiqua A, Ward DT et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 2004; 101: 5140-5145. (Pubitemid 38469215)
57. Tu Q, Pi M, Karsenty G et al. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 2003; 111: 1029-1037. (Pubitemid 36397479)
58. Kos CH, Karaplis AC, Peng JB et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 2003; 111: 1021-1028. (Pubitemid 36397478)
59. Rodriguez L, Tu C, Cheng Z et al. Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. Endocrinology 2005; 146: 5294-5303. (Pubitemid 41653042)
60. Masuyama R, Vriens J, Voets T et al. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab 2008; 8: 257-265.
61. van der Eerden BC, Weissgerber P, Fratzl-Zelman N et al. The transient receptor potential channel TRPV6 is dynamically expressed in bone cells but is not crucial for bone mineralization in mice. J Cell Physiol 2011; 227: 1951-1959.
62. Hoenderop JG, van Leeuwen JP, van der Eerden BC et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 2003; 112: 1906-1914. (Pubitemid 38063714)
63. van der Eerden BC, Hoenderop JG, de Vries TJ et al. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc Natl Acad Sci USA 2005; 102: 17507-17512. (Pubitemid 41740896)
64. Boskey AL, Rimnac CM, Bansal M et al. Effect of short-term hypomagnesemia on the chemical and mechanical properties of rat bone. J Orthop Res 1992; 10: 774-783.
65. Navarro JF, Mac?́a ML, Gallego E et al. Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 1997; 31: 275-280. (Pubitemid 27293673)
66. Rude RK, Gruber HE. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem 2004; 15: 710-716. (Pubitemid 40018113)
67. Abed E, Martineau C, Moreau R. Role of melastatin transient receptor potential 7 channels in the osteoblastic differentiation of murine MC3T3 cells. Calcif Tissue Int 2011; 88: 246-253.
68. Groenestege WM, Hoenderop JG, van den Heuvel L et al. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol 2006; 17: 1035-1043.
69. Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf) 2008; 69: 338-341. (Pubitemid 352009025)
70. McCarthy DM. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol 2010; 26: 624-631.
71. D'Haese PC, Couttenye MM, Lamberts LV et al. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 1999; 45: 1548-1556.
72. Navarro-Gonzalez JF. Magnesium in dialysis patients: serum levels and clinical implications. Clin Nephrol 1998; 49: 373-378. (Pubitemid 28271469)
73. Geibel JP, Hebert SC. The functions and roles of the extracellular Ca2+-sensing receptor along the gastrointestinal tract. Annu Rev Physiol 2009; 71: 205-217.
74. van Abel M, Hoenderop JG, van der Kemp AW et al. Regulation of the epithelial Ca2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest Liver Physiol 2003; 285: G78-G85. (Pubitemid 36736391)
75. Fine KD, Santa Ana CA, Porter JL et al. Intestinal absorption of magnesium from food and supplements. J Clin Invest 1991; 88: 396-402.
76. Pollak MR, Brown EM, Chou YH et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-1303.
77. Anast CS, Forte LF. Parathyroid function and magnesium depletion in the rat. Endocrinology 1983; 113: 184-189. (Pubitemid 13045135)
78. Woudenberg-Vrenken TE, Sukinta A, van der Kemp AW et al. Transient receptor potential melastatin 6 knockout mice are lethal whereas heterozygous deletion results in mild hypomagnesemia. Nephron Physiol 2011; 117: p11-p19.
79. Shalev H, Phillip M, Galil A et al. Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child 1998; 78: 127-130. (Pubitemid 28136194)
80. Bonny O, Rubin A, Huang C-L et al. Mechanism of urinary calcium regulation by urinary magnesium and pH. J Am Soc Nephrol 2008; 19: 1530-1537.
81. Anast CS, Winnacker JL, Forte LR et al. Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 1976; 42: 707-717.
82. Mennes P, Rosenbaum R, Martin K et al. Hypomagnesemia and impaired parathyroid hormone secretion in chronic renal disease. Ann Intern Med 1978; 88: 206-209. (Pubitemid 8282154)
83. Allen DB, Friedman AL, Greer FR et al. Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudohypoparathyroidism. Am J Med Genet 1988; 31: 153-158.
84. Anast CS, Mohs JM, Kaplan SL et al. Evidence for parathyroid failure in magnesium deficiency. Science 1972; 177: 606-608.
85. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 2006; 355: 1834-1836.
86. Iwasaki Y, Asai M, Yoshida M et al. Impaired parathyroid hormone response to hypocalcemic stimuli in a patient with hypomagnesemic hypocalcemia. J Endocrinol Invest 2007; 30: 513-516. (Pubitemid 47496462)
87. Raisz LG, Niemann I. Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 1969; 85: 446-452.
88. Freitag JJ, Martin KJ, Conrades MB et al. Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. J Clin Invest 1979; 64: 1238-1244.
89. Graber ML, Schulman G. Hypomagnesemic hypocalcemia independent of parathyroid hormone. Ann Intern Med 1986; 104: 804-805. (Pubitemid 16115047)
90. Panda DK, Miao D, Tremblay ML et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001; 98: 7498-7503. (Pubitemid 32567977)
91. Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561-568. (Pubitemid 38542505)
92. Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51. (Pubitemid 27494749)
93. Chang Q, Hoefs S, van der Kemp AW et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005; 310: 490-493. (Pubitemid 41507962)
94. Imura A, Tsuji Y, Murata M et al. Alpha-klotho as a regulator of calcium homeostasis. Science 2007; 316: 1615-1618.
95. Kurosu H, Kuro OM. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 2009; 299: 72-78.
96. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444: 770-774. (Pubitemid 44949607)
97. Kolek OI, Hines ER, Jones MD et al. 1Alpha,25-dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005; 289: G1036-G1042. (Pubitemid 41740608)
98. Perwad F, Azam N, Zhang MY et al. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 2005; 146: 5358-5364. (Pubitemid 41653049)
99. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435. (Pubitemid 38787398)
100. Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131. (Pubitemid 350056006)
101. Tsujikawa H, Kurotaki Y, Fujimori T et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17: 2393-2403. (Pubitemid 37542205)
102. Marsell R, Krajisnik T, Goransson H et al. Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. Nephrol Dial Transplant 2008; 23: 827-833. (Pubitemid 351767553)
103. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011; 22: 124-136.
104. Nakatani T, Sarraj B, Ohnishi M et al. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J 2009; 23: 433-441.
105. Nakatani T, Ohnishi M, Razzaque MS. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 2009; 23: 3702-3711.
106. Tzanakis I, Pras A, Kounali D et al. Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 1997; 12: 2036-2037. (Pubitemid 27379500)
107. Turgut F, Kanbay M, Metin MR et al. Magnesium supplementation helps to improve carotid intima-media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40: 1075-1082.
108. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 2008; 294: H1103-H1118. (Pubitemid 351468705)
109. Maier JA, Bernardini D, Rayssiguier Y et al. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta 2004; 1689: 6-12. (Pubitemid 38670497)
110. Calò L, Punzi L, Semplicini A. Hypomagnesemia and chondrocalcinosis in Bartter's and Gitelman's syndrome: review of the pathogenetic mechanisms. Am J Nephrol 2000; 20: 347-350.
111. Neven E, De Schutter TM, De Broe ME et al. Cell biological and physicochemical aspects of arterial calcification. Kidney Int 2011; 79: 1166-1177.
112. Lopez I, Mendoza FJ, Aguilera-Tejero E et al. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int 2008; 73: 300-307.
113. Ivanovski O, Nikolov IG, Joki N et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE/) mice. Atherosclerosis 2009; 205: 55-62.
114. Alam MU, Kirton JP, Wilkinson FL et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 2009; 81: 260-268.
115. Molostvov G, James S, Fletcher S et al. Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 2007; 293: F946-F955. (Pubitemid 47403367)
116. Chow JY, Estrema C, Orneles T et al. Calcium-sensing receptor modulates extracellular Ca2+ entry via TRPC-encoded receptor-operated channels in human aortic smooth muscle cells. Am J Physiol Cell Physiol 2011; 301: C461-C468.
117. Montezano AC, Zimmerman D, Yusuf H et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 56: 453-462.
118. Ohnishi M, Nakatani T, Lanske B et al. Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 2009; 75: 1166-1172.
119. Briese S, Wiesner S, Will JC et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 2006; 21: 1906-1914. (Pubitemid 43985719)
120. Krejs GJ, Nicar MJ, Zerwekh JE et al. Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med 1983; 75: 973-976. (Pubitemid 14204588)
121. Hutchison AJ. Oral phosphate binders. Kidney Int 2009; 75: 906-914.
122. de Francisco ALM, Leidig M, Covic AC et al. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010; 25: 3707-3717.
123. Heath III H, Jackson CE, Otterud B et al. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 1993; 53: 193-200. (Pubitemid 23313750)
124. Trump D, Whyte MP, Wooding C et al. Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet 1995; 96: 183-187.
125. Janicic N, Soliman E, Pausova Z et al. Mapping of the calciumsensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 1995; 6: 798-801.
126. Lloyd SE, Pannett AA, Dixon PH et al. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 1999; 64: 189-195. (Pubitemid 30428972)
127. Nesbit MA, Hannan FM, Graham U et al. Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a o3.5 megabase pair region on chromosome 19q13.3. J Clin Endocrinol Metab 2010; 95: 1947-1954.
128. Hannan FM, Nesbit MA, Turner JJ et al. Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calciumsensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3. Eur J Hum Genet 2010; 18: 442-447.
129. Véscovi EG, Ayala YM, Di Cera E et al. Characterization of the bacterial sensor protein PhoQ. Evidence for distinct binding sites for Mg2+ and Ca2+. J Biol Chem 1997; 272: 1440-1443. (Pubitemid 27043217)
130. Quamme GA. Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol 2010; 298: C407-C429.
131. Ferre S, Hoenderop JG, Bindels RJ. Insight into renal Mg2+ transporters. Curr Opin Nephrol Hypertens 2011; 20: 169-176.
132. Groenestege WM, Thebault S, van der Wijst J et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2007; 117: 2260-2267. (Pubitemid 47219571)